This page contains brief information about brigatinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Brigatinib is approved to treat:
- Non-small cell lung cancer that has a mutation in the anaplastic lymphoma kinase (ALK) gene and has metastasized (spread to other parts of the body). Brigatinib is used in patients who cannot be treated with crizotinib or have gotten worse while taking crizotinib.
Brigatinib is also being studied in the treatment of other types of cancer.
More About Brigatinib
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Brigatinib - Check for trials from NCI's list of cancer clinical trials now accepting patients.